{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:52:31Z","timestamp":1785466351711,"version":"3.56.0"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/gme.0b013e3181a95581","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T08:17:35Z","timestamp":1262679455000},"page":"194-203","source":"Crossref","is-referenced-by-count":117,"title":["Efficacy and tolerability of local estrogen therapy for urogenital atrophy"],"prefix":"10.1097","volume":"17","author":[{"given":"David F.","family":"Archer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-35-20210227","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1743-6109.2005.00129.x","article-title":"Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition.","volume":"2","author":"Graziottin","year":"2005","journal-title":"J Sex Med"},{"key":"R3-35-20210227","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/gme.0b013e318051718c","article-title":"The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.","volume":"14","year":"2007","journal-title":"Menopause"},{"key":"R4-35-20210227","first-page":"722","article-title":"Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee.","volume":"92","author":"Cardozo","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R5-35-20210227","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/bmj.321.7275.1516","article-title":"Extracts from \"clinical evidence\": menopausal symptoms.","volume":"321","author":"Rymer","year":"2000","journal-title":"BMJ"},{"key":"R6-35-20210227","first-page":"351","article-title":"A prospective population-based study of menopausal symptoms.","volume":"96","author":"Dennerstein","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R7-35-20210227","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1532-5415.2005.00613.x","article-title":"The effect of age on lower urinary tract function: a study in women.","volume":"54","author":"Pfisterer","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"R8-35-20210227","first-page":"3090","article-title":"Diagnosis and treatment of atrophic vaginitis.","volume":"61","author":"Bachmann","year":"2000","journal-title":"Am Fam Physician"},{"key":"R9-35-20210227","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-2005-869480","article-title":"Vaginal hormone therapy for urogenital and menopausal symptoms.","volume":"23","author":"Ballagh","year":"2005","journal-title":"Semin Reprod Med"},{"key":"R10-35-20210227","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1001\/jama.281.23.2173","article-title":"Survey says patients expect little physician help on sex Medical News & Perspectives.","volume":"281","author":"Marwick","year":"1999","journal-title":"JAMA"},{"key":"R11-35-20210227","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s11606-007-0296-z","article-title":"How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes.","volume":"22","author":"Bush","year":"2007","journal-title":"J Gen Intern Med"},{"key":"R12-35-20210227","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.maturitas.2005.06.014","article-title":"Management of post-menopausal vaginal atrophy and atrophic vaginitis.","volume":"52","author":"Castelo-Branco","year":"2005","journal-title":"Maturitas"},{"key":"R13-35-20210227","first-page":"1299","article-title":"Alternative treatments for menopausal symptoms. Systematic review of scientific and lay literature.","volume":"44","author":"Seidl","year":"1998","journal-title":"Can Fam Physician"},{"key":"R14-35-20210227","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/clinchem\/37.6.838","article-title":"Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay.","volume":"37","author":"Munro","year":"1991","journal-title":"Clin Chem"},{"key":"R15-35-20210227","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/00007611-198708000-00013","article-title":"Vaginal physiology in postmenopausal women: pH value, transvaginal electropotential difference, and estimated blood flow.","volume":"80","author":"Tsai","year":"1987","journal-title":"South Med J"},{"key":"R16-35-20210227","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000293384","article-title":"Changes in urethral cytology following estrogen administration.","volume":"29","author":"Bergman","year":"1990","journal-title":"Gynecol Obstet Invest"},{"key":"R17-35-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00016349309156514","article-title":"Estrogens and the urogenital tract: studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring.","volume":"72","author":"Smith","year":"1993","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R18-35-20210227","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/cyto.990110607","article-title":"Histomorphometric study of the lower urogenital tract in pre- and post-menopausal women.","volume":"11","author":"Semmelink","year":"1990","journal-title":"Cytometry"},{"key":"R19-35-20210227","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/nau.10089","article-title":"Computerised morphometric study of the paraurethral tissue in young and elderly women.","volume":"21","author":"Verelst","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"R20-35-20210227","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/0378-5122(95)00960-4","article-title":"Estrogen therapy in the management of problems associated with urogenital ageing: a simple diagnostic test and the effect of the route of hormone administration.","volume":"22","author":"Notelovitz","year":"1995","journal-title":"Maturitas"},{"key":"R21-35-20210227","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1089\/152460900318830","article-title":"Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause.","volume":"9","author":"Sarrel","year":"2000","journal-title":"J Womens Health Gend Based Med"},{"key":"R22-35-20210227","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jama.1982.03330040033027","article-title":"Estrogen deprivation and vaginal function in postmenopausal women.","volume":"248","author":"Semmens","year":"1982","journal-title":"JAMA"},{"key":"R23-35-20210227","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/01443610120059941","article-title":"Vaginal oestradiol for the treatment of lower urinary tract symptoms in postmenopausal women-a double-blind placebo-controlled study.","volume":"21","author":"Cardozo","year":"2001","journal-title":"J Obstet Gynaecol"},{"key":"R24-35-20210227","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00042192-200205000-00006","article-title":"Treatment of urogenital atrophy with low-dose estradiol: preliminary results.","volume":"9","author":"Santen","year":"2002","journal-title":"Menopause"},{"key":"R25-35-20210227","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0002-9378(89)90114-2","article-title":"Effects of estrogen on urethral function in women with urinary incontinence.","volume":"160","author":"Bhatia","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"R26-35-20210227","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women (review).","volume":"4","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R27-35-20210227","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0029-7844(97)00439-0","article-title":"Factors affecting detrusor contraction strength during voiding in women.","volume":"90","author":"Karram","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R28-35-20210227","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/nau.20381","article-title":"Parameters of bladder function in pre-, peri-, and postmenopausal continent women without detrusor overactivity.","volume":"26","author":"Pfisterer","year":"2007","journal-title":"Neurourol Urodyn"},{"key":"R29-35-20210227","first-page":"208","article-title":"Urodynamic changes following hormonal replacement therapy in women with premature ovarian failure.","volume":"74","author":"Karram","year":"1989","journal-title":"Obstet Gynecol"},{"key":"R30-35-20210227","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/01.ju.0000107261.64927.b3","article-title":"Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection.","volume":"171","author":"Stern","year":"2004","journal-title":"J Urol"},{"key":"R31-35-20210227","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1089\/154099902762203704","article-title":"Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.","volume":"11","author":"Crandall","year":"2002","journal-title":"J Womens Health"},{"key":"R32-35-20210227","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.fertnstert.2005.06.042","article-title":"A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women.","volume":"85","author":"Long","year":"2006","journal-title":"Fertil Steril"},{"key":"R33-35-20210227","first-page":"CD005131","article-title":"Oestrogens for preventing recurrent urinary tract infection in postmenopausal women.","volume":"16","author":"Perrotta","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R34-35-20210227","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk.","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"R35-35-20210227","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2007-0026","article-title":"Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study.","volume":"92","author":"Sitruk-Ware","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-35-20210227","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00006254-198404000-00022","article-title":"17-Estradiol for postmenopausal estrogen replacement therapy.","volume":"39","author":"Nichols","year":"1984","journal-title":"Obstet Gynecol Surv"},{"key":"R37-35-20210227","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.gme.0000227401.98933.0b","article-title":"A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women.","volume":"13","author":"Long","year":"2006","journal-title":"Menopause"},{"key":"R38-35-20210227","first-page":"799","article-title":"Recent advances in hormone replacement therapy.","volume":"49","author":"Smith","year":"1993","journal-title":"Br J Hosp Med"},{"key":"R39-35-20210227","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.","volume":"75","author":"Utian","year":"2001","journal-title":"Fertil Steril"},{"key":"R40-35-20210227","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1447-0756.2001.tb01266.x","article-title":"The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study.","volume":"27","author":"Manonai","year":"2001","journal-title":"J Obstet Gynaecol Res"},{"key":"R41-35-20210227","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0378-5122(92)90246-Z","article-title":"Low-dose oestradiol in the treatment of urogenital oestrogen deficiency-a pharmacokinetic and pharmacodynamic study.","volume":"15","author":"Nilsson","year":"1992","journal-title":"Maturitas"},{"key":"R42-35-20210227","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1034\/j.1600-0412.2000.079004293.x","article-title":"Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.","volume":"79","author":"Dugal","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R43-35-20210227","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0378-5122(95)00943-F","article-title":"Transvaginal estriol administration in postmenopausal women: a double blind comparative study of two different doses.","volume":"22","author":"Bottiglione","year":"1995","journal-title":"Maturitas"},{"key":"R44-35-20210227","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00042192-200007030-00005","article-title":"17-Estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.","volume":"7","author":"Rioux","year":"2000","journal-title":"Menopause"},{"key":"R45-35-20210227","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0378-5122(88)90066-7","article-title":"Serum levels of oestrogens, progesterone, follicle-stimulating hormone and sex-hormone-binding globulin during simultaneous vaginal administration of 17-oestradiol and progesterone in the pre- and post-menopause.","volume":"10","author":"Carlstrom","year":"1988","journal-title":"Maturitas"},{"key":"R46-35-20210227","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0378-5122(94)00865-5","article-title":"Low-dose 17-oestradiol during maintenance therapy-a pharmacokinetic and pharmacodynamic study.","volume":"21","author":"Nilsson","year":"1995","journal-title":"Maturitas"},{"key":"R48-35-20210227","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/gme.0b013e31803167ab","article-title":"Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.","volume":"14","year":"2007","journal-title":"Menopause"},{"key":"R49-35-20210227","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0378-5122(91)90092-5","article-title":"Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints.","volume":"13","author":"Foidart","year":"1991","journal-title":"Maturitas"},{"key":"R50-35-20210227","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM199309093291102","article-title":"A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.","volume":"329","author":"Raz","year":"1993","journal-title":"N Engl J Med"},{"key":"R51-35-20210227","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0301-2115(96)02612-7","article-title":"Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.","volume":"71","author":"Barentsen","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R52-35-20210227","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9378(97)70448-4","article-title":"Bone loss in elderly women prevented by ultralow doses of parenteral 17-estradiol.","volume":"177","author":"Naessen","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R53-35-20210227","first-page":"2757","article-title":"Serum lipid profile improved by ultra-low doses of 17-estradiol in elderly women.","volume":"86","author":"Naessen","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R54-35-20210227","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/13621807010070S344","article-title":"Serum oestradiol concentrations following single-dose administration of oestradiol acetate intravaginal rings (IVRs) delivering 50, 75, and 100 mcg\/day oestradiol in healthy post-menopausal women.","volume":"7","author":"Passmore","year":"2001","journal-title":"J Br Menopause Soc"},{"key":"R55-35-20210227","first-page":"823","article-title":"Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms.","volume":"102","author":"Speroff","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R56-35-20210227","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.AOG.0000296714.12226.0f","article-title":"Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.","volume":"111","author":"Bachmann","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R57-35-20210227","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/AOG.0b013e31818aa7c3","article-title":"Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.","volume":"112","author":"Simon","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R58-35-20210227","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/jwh.2007.0407","article-title":"A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practice.","volume":"17","author":"Shulman","year":"2008","journal-title":"J Womens Health (Larchmt)"},{"key":"R59-35-20210227","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2007.08.010","article-title":"Intravaginal oestrogen and progestin administration: advantages and disadvantages.","volume":"22","author":"Cicinelli","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R60-35-20210227","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-2005-869487","article-title":"Lower doses of oral estrogen and progestogens as treatment for postmenopausal women.","volume":"23","author":"Archer","year":"2005","journal-title":"Semin Reprod Med"},{"key":"R61-35-20210227","first-page":"4462","article-title":"The effect of low dose micronized 17-estradiol on bone turnover, sex hormone levels, and side effects in older women: a randomized, double blind, placebo-controlled study.","volume":"85","author":"Prestwood","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R62-35-20210227","first-page":"366","article-title":"Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations.","volume":"96","author":"Symons","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R63-35-20210227","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0002-9378(99)70438-2","article-title":"Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients.","volume":"181","author":"Utian","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R64-35-20210227","first-page":"726","article-title":"Initial 17-estradiol dose for treating vasomotor symptoms.","volume":"95","author":"Notelovitz","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R65-35-20210227","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/jama.1996.03540170041030","article-title":"The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART Study): a randomized controlled trial.","volume":"276","author":"Speroff","year":"1996","journal-title":"JAMA"},{"key":"R66-35-20210227","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.maturitas.2006.08.004","article-title":"Benefits and risks of long-term low-dose oral continuous combined hormone therapy.","volume":"56","author":"van de Weijer","year":"2006","journal-title":"Maturitas"},{"key":"R67-35-20210227","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0002-9378(94)90074-4","article-title":"A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.","volume":"171","author":"Henriksson","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"R68-35-20210227","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejogrb.2006.01.025","article-title":"Transvaginal color Doppler sonographic assessment of uterus and ovaries in postmenopausal women: the effect of local estrogen treatment.","volume":"127","author":"Manonai","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R69-35-20210227","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13697130500087016","article-title":"Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.","volume":"8","author":"Weisberg","year":"2005","journal-title":"Climacteric"},{"key":"R70-35-20210227","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.maturitas.2007.02.025","article-title":"Rationale for use of lower estrogen doses for postmenopausal hormone therapy.","volume":"57","author":"Ettinger","year":"2007","journal-title":"Maturitas"},{"key":"R71-35-20210227","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0378-5122(92)90208-L","article-title":"Preoperative treatment with oestradiol in women scheduled for vaginal operation for genital prolapse. A randomised, double-blind trial.","volume":"15","author":"Felding","year":"1992","journal-title":"Maturitas"},{"key":"R72-35-20210227","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0378-5122(91)90144-F","article-title":"Long-term treatment of atrophic vaginitis with low-dose oestradiol vaginal tablets.","volume":"14","author":"Mettler","year":"1991","journal-title":"Maturitas"},{"key":"R73-35-20210227","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0378-5122(89)90120-5","article-title":"Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy.","volume":"11","author":"Holmgren","year":"1989","journal-title":"Maturitas"},{"key":"R74-35-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"R75-35-20210227","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.","volume":"291","author":"Women's Health Initiative Steering Committee, Anderson","year":"2004","journal-title":"JAMA"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042192-201017010-00035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T12:57:05Z","timestamp":1711112225000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201017010-00035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3181a95581","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}